Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2008-04-23

FDA Approved: APLENZIN — Original Application (Bausch Health US, LLC)

View source ↗

Summary

FDA approved APLENZIN (bupropion hydrobromide) through an original application for the treatment of major depressive disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • APLENZIN (BUPROPION HYDROBROMIDE)

Snippet

ORIG AP for APLENZIN (BUPROPION HYDROBROMIDE)